VINCIARELLI PATRIZIO sold $7.2M of VICR

VINCIARELLI PATRIZIO (Chairman & CEO) sold 20,000 shares of VICOR CORP (VICR) at an average of $360.94 ($351.72–$368.80, $7.22M total) across 16 trades on 2026-06-22 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · VINCIARELLI PATRIZIO
Published Jun 24, 2026, 5:51 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 24, 2026, 5:51 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$VICR
Bearish
medium confidence
Mentioned
$VICR
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRBearishLow
01

Why it matters

Traders may monitor for follow-on insider activity or changes in trading patterns, but this disclosure alone does not provide new operational or financial guidance.

02

Market read

A sizable insider sale under 10b5-1 can create mild negative sentiment, but it is typically lower-signal than discretionary selling.

03

What to watch

The filing date (2026-06-24) may lag the actual sale date (2026-06-22), so market reaction may already be partially priced.

Relevance 5/10Novelty 5/10Timing: Filed 2026-06-24 after-hours/late session; relevant for next-session positioning around insider-sale headlines.

Background

The filing is an SEC Form 4 insider transaction for Vicor Corp, reported by its Chairman & CEO under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$VICRBearishMedium confidence
Context

VICR’s CEO/Chairman sold about $7.22M of VICR shares via an open-market sale under a pre-arranged 10b5-1 plan.

Expected impact

Likely limited, short-lived sentiment pressure; any impact should be smaller because the sale is under a 10b5-1 plan.

Evidence & confidence

Form 4 shows a large dollar value transaction, but the presence of a pre-arranged 10b5-1 plan reduces the signal of new information.

Market effects

No sector-wide read-through; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

A 10b5-1 sale is often routine liquidity planning; it may not reflect bearish expectations and can be neutral for fundamentals.

Key entities

  • VICOR CORP

    Subject of the Form 4 insider transaction; CEO/Chairman sold shares totaling ~$7.22M.

  • VINCIARELLI PATRIZIO

    Chairman & CEO and 10% owner who executed the open-market sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$VICRMed

VICR SWOT Analysis: Strong Revenue Growth and Patent Settlement

Vicor Corp (VICR) reported Q3 2026 revenue of $197.1M, up 78.5% YoY, driven by product sales and royalty revenue. Gross margin increased to 68.3%. The company has a strong order backlog of $406M but faces valuation concerns and customer concentration risks. It has growth opportunities in EVs and renewable energy. VICR's GF Score is 82/100, with high growth and profitability ratings but low valuation.

$VICRHigh

VICR Stock Surges On Blowout Q3 And Aggressive Capacity Bet

Vicor Corporation (VICR) stock rose 12.95% after reporting Q3 2026 revenue of $197.1M, up 78.5% YoY, with gross margin at 68.3%. The company's backlog and operating cash flow increased, driven by AI and high-performance systems demand. VICR is expanding capacity and faces an ITC investigation. Analysts raised price targets to $350-$360.

$VICRHighAI 8/10

Why is Vicor stock climbing today?

Vicor Corporation (VICR) stock rose 2.6% in morning trading, extending gains after its Q3 2026 earnings beat expectations. Revenue was $197.1M, up 78.5% YoY, with adjusted EPS of $1.33. Gross margin expanded to 68.3%, and the order backlog grew 166% YoY to $406M. Analysts maintained Buy ratings with price targets of $350 and $375. The stock traded at $209.36, above its 52-week low of $79 but below its high of $382.65.